Manning Paul B

CIK 0001494695

Director10% Owner

Filings

Latest Apr 2, 2026

Issuers covered

Showing

27 of 27

Page 1

Track record

24 of 24 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	24	58%	+8.6%	+7.5%	+70.5%	-29.2%
90 days	24	33%	-6.2%	-13.8%	+102.1%	-45.1%
180 days	23	35%	-2.7%	-12.4%	+89.4%	-47.3%
365 days	17	47%	-3.9%	-6.7%	+167.4%	-84.6%

Issuers

Companies where Manning Paul B has filed

Ticker	Issuer	Filings	Last filed
LQDA	Liquidia Corp	10	Feb 12, 2026
CADL	Candel Therapeutics, Inc.	7	Apr 2, 2026
TSHA	Taysha Gene Therapies, Inc.	6	Jun 3, 2025
VRCA	Verrica Pharmaceuticals Inc.	4	Nov 25, 2025

All filings

27 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Apr 2, 2026	CADLCandel Therapeutics, Inc.	Holdings only	-	-	-
Feb 26, 2026	CADLCandel Therapeutics, Inc.	PPurchase	550,458	$5.45	$2,999,996
Feb 12, 2026	LQDALiquidia Corp	JOther	55,116	$42.63	$2,349,595
Nov 25, 2025	VRCAVerrica Pharmaceuticals Inc.	PPurchase	2,750,762	$4.2425	$11,670,108
Sep 2, 2025	LQDALiquidia Corp	SSale	254,038	$28.67	$7,283,269
Jun 26, 2025	CADLCandel Therapeutics, Inc.	AGrant	1,070,663	$4.67	$4,999,996
Jun 20, 2025	LQDALiquidia Corp	AGrant	18,396	$0.00	$0
Jun 18, 2025	CADLCandel Therapeutics, Inc.	Holdings only	-	-	-
Jun 3, 2025	TSHATaysha Gene Therapies, Inc.	PPurchase	750,000	$2.75	$2,062,500
Dec 18, 2024	CADLCandel Therapeutics, Inc.	PPurchase	750,000	$6.00	$4,500,000
Nov 26, 2024	VRCAVerrica Pharmaceuticals Inc.	PPurchase	18,426,966	-	-
Sep 23, 2024	VRCAVerrica Pharmaceuticals Inc.	GGift	2,675,611.25	$0.00	$0
Sep 16, 2024	LQDALiquidia Corp	PPurchase	337,078	$8.90	$2,999,994
Jul 1, 2024	TSHATaysha Gene Therapies, Inc.	PPurchase	1,333,333	$2.25	$2,999,999
Jun 27, 2024	CADLCandel Therapeutics, Inc.	Holdings only	-	-	-
Jun 24, 2024	LQDALiquidia Corp	AGrant	20,359	$0.00	$0
Dec 18, 2023	LQDALiquidia Corp	PPurchase	279,330	$7.16	$2,000,003
Nov 20, 2023	TSHATaysha Gene Therapies, Inc.	PPurchase	100,000	$1.63	$163,000
Aug 16, 2023	TSHATaysha Gene Therapies, Inc.	PPurchase	16,466,667	$0.90	$14,820,000
Jul 24, 2023	VRCAVerrica Pharmaceuticals Inc.	PPurchase	200,000	$5.02	$1,004,000
Jun 29, 2023	CADLCandel Therapeutics, Inc.	Holdings only	-	-	-
Jun 21, 2023	LQDALiquidia Corp	Holdings only	-	-	-
Jun 22, 2022	LQDALiquidia Corp	Holdings only	-	-	-
Jun 22, 2022	TSHATaysha Gene Therapies, Inc.	Holdings only	-	-	-
Apr 20, 2022	LQDALiquidia Corp	AGrant	435,674	$0.00	$0
Apr 19, 2022	LQDALiquidia Corp	PPurchase	392,156	$5.10	$1,999,996
Feb 4, 2022	TSHATaysha Gene Therapies, Inc.	PPurchase	58,000	$7.77	$450,660

Showing 1-27 of 27

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value